Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 18.27M
March 31, 2026 20.47M
December 31, 2025 20.62M
September 30, 2025 45.81M
June 30, 2025 29.68M
March 31, 2025 28.74M
December 31, 2024 27.61M
September 30, 2024 15.77M
June 30, 2024 15.49M
March 31, 2024 13.27M
December 31, 2023 3.280M
September 30, 2023 2.648M
June 30, 2023 3.446M
March 31, 2023 2.821M
December 31, 2022 2.698M
September 30, 2022 6.926M
June 30, 2022 18.12M
March 31, 2022 18.07M
December 31, 2021 19.61M
September 30, 2021 19.39M
June 30, 2021 6.740M
March 31, 2021 3.581M
Date Value
December 31, 2020 15.56M
September 30, 2020 2.657M
June 30, 2020 7.659M
March 31, 2020 5.143M
December 31, 2019 4.286M
September 30, 2019 6.234M
June 30, 2019 6.664M
March 31, 2019 6.243M
December 31, 2018 2.996M
September 30, 2018 3.046M
June 30, 2018 4.111M
March 31, 2018 4.149M
December 31, 2017 3.819M
September 30, 2017 4.041M
June 30, 2017 4.120M
March 31, 2017 3.953M
December 31, 2016 3.541M
September 30, 2016 17.95M
June 30, 2016 15.81M
March 31, 2016 11.73M
December 31, 2015 10.32M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 406.66M
Alnylam Pharmaceuticals, Inc. 4.391B
Anika Therapeutics, Inc. 46.19M
Savara, Inc. 48.48M
Vericel Corp. 132.82M

Total Liabilities (Quarterly) Related Metrics